Study of serum interleukin 17 level in children with bronchial asthma
Not Applicable
- Conditions
- RespiratoryPaediatrics
- Registration Number
- PACTR201602001487159
- Lead Sponsor
- mohammed sami bazzari
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 85
Inclusion Criteria
Every Asthmatic child had at least three attacks of (paroxysmal dyspnea, cough, and wheeze).
Attack was relived spontaneously or with treatment (mainly with beta 2 agonist).
Patients had to be completely symptoms free for at least 2 weeks in between attacks.
Asthmatic children had to fulfill the criteria of asthmatic diagnosis of GINA guidelines (2014) [6].
Exclusion Criteria
Any patient had been used systemic corticosteroid in order not to affect Interleukin 17 serum level.
Patients were diagnosed with any of Asthma differential diagnoses diseases
Patients were known as a carrier of a blood transmitted infectious disease or had suffered from conditions in which phlebotomy was contraindicated.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method There was a highly significant difference in serum levels of IL-17 and total IgE in asthmatic than in control groups in children.
- Secondary Outcome Measures
Name Time Method There was also insignificant positive correlation between IL-17and IgE